Adjuvant treatment Grade 3, 4, or 5 Cure Liquid tumor Carcinoma Benign Sarcoma Lymphoma Recurrence or relapse Multiple myeloma Maintenance chemotherapy Neoadjuvant treatment Refractory Cancer Clinical stage Complementary therapy Definitive treatment Monoclonal antibody TNM staging system Minimal residual disease Adenocarcinoma Tyrosine kinase inhibitors (TKIs) Surgical margin Partial remission Complete remission Palliation Antibody drug conjugate Cellular therapy Tumor Pathological stage Performance status Active surveillance ECOG performance status Chemotherapy CTCAE Checkpoint inhibitor Leukemia PET scan Adjuvant treatment Grade 3, 4, or 5 Cure Liquid tumor Carcinoma Benign Sarcoma Lymphoma Recurrence or relapse Multiple myeloma Maintenance chemotherapy Neoadjuvant treatment Refractory Cancer Clinical stage Complementary therapy Definitive treatment Monoclonal antibody TNM staging system Minimal residual disease Adenocarcinoma Tyrosine kinase inhibitors (TKIs) Surgical margin Partial remission Complete remission Palliation Antibody drug conjugate Cellular therapy Tumor Pathological stage Performance status Active surveillance ECOG performance status Chemotherapy CTCAE Checkpoint inhibitor Leukemia PET scan
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Adjuvant treatment
Grade 3, 4, or 5
Cure
Liquid tumor
Carcinoma
Benign
Sarcoma
Lymphoma
Recurrence or relapse
Multiple myeloma
Maintenance chemotherapy
Neoadjuvant treatment
Refractory
Cancer
Clinical stage
Complementary therapy
Definitive treatment
Monoclonal antibody
TNM staging system
Minimal residual disease
Adenocarcinoma
Tyrosine kinase inhibitors (TKIs)
Surgical margin
Partial remission
Complete remission
Palliation
Antibody drug conjugate
Cellular therapy
Tumor
Pathological stage
Performance status
Active surveillance
ECOG performance status
Chemotherapy
CTCAE
Checkpoint inhibitor
Leukemia
PET scan